Chimerism Split Cell Analysis Myeloid Cell CD15 Test
Comprehensive Introduction to Chimerism Analysis
The Chimerism Split Cell Analysis Myeloid Cell CD15 Test represents a cutting-edge diagnostic approach in the field of bone marrow transplantation monitoring. This sophisticated laboratory procedure plays a crucial role in evaluating the success of hematopoietic stem cell transplantation by specifically analyzing the myeloid cell lineage. The test provides healthcare providers with essential data about the proportion of donor-derived cells versus recipient cells, enabling precise assessment of engraftment success and early detection of potential complications.
What Does This Test Measure and Detect?
This specialized test employs advanced molecular techniques to quantify the percentage of donor and recipient cells within the myeloid lineage, specifically targeting CD15-positive cells. The analysis provides:
- Precise quantification of donor cell engraftment in myeloid lineage
- Detection of mixed chimerism patterns indicating transplant success
- Early identification of graft rejection or relapse
- Monitoring of minimal residual disease in transplant recipients
- Assessment of immune reconstitution following transplantation
Who Should Consider This Test?
This test is specifically designed for patients who have undergone bone marrow or stem cell transplantation. Key indications include:
- Patients post-hematopoietic stem cell transplantation
- Individuals requiring monitoring of graft versus host disease
- Patients with hematological malignancies undergoing transplant therapy
- Individuals showing signs of potential graft failure or rejection
- Patients requiring assessment of treatment response
Significant Benefits of Chimerism Testing
Undergoing regular chimerism analysis provides numerous clinical advantages:
- Early detection of transplant complications allowing timely intervention
- Accurate assessment of engraftment success and stability
- Guidance for immunosuppressive therapy adjustments
- Monitoring of disease remission status
- Improved long-term transplant outcomes through proactive management
- Reduced risk of relapse through continuous monitoring
Understanding Your Test Results
Your chimerism analysis results will provide valuable insights into your transplant status:
- Complete Donor Chimerism: Indicates successful engraftment with 100% donor cells
- Mixed Chimerism: Shows presence of both donor and recipient cells, requiring careful monitoring
- Decreasing Donor Chimerism: May indicate graft rejection or disease relapse
- Stable Mixed Chimerism: Often represents successful engraftment with balanced immune function
Your healthcare provider will interpret these results in the context of your specific medical condition and treatment plan.
Test Pricing Information
| Test Name | Discount Price | Regular Price |
|---|---|---|
| Chimerism Split Cell Analysis Myeloid Cell CD15 Test | $262 USD | $376 USD |
Convenient Testing Locations Across USA
We have established testing facilities in all major cities throughout the United States, including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our state-of-the-art laboratories ensure consistent, high-quality results with rapid turnaround times.
Schedule Your Test Today
Take control of your transplant monitoring and ensure optimal outcomes with our comprehensive Chimerism Split Cell Analysis. Our experienced team is ready to assist you with scheduling and answer any questions you may have about the testing process.
Call us now at +1(267) 388-9828 to book your Chimerism Split Cell Analysis Myeloid Cell CD15 Test and take the next step in your transplant monitoring journey.
Sample Requirements: 4 ml (2 ml minimum) whole blood or bone marrow in 1 Lavender Top (EDTA) tube. Ship refrigerated. DO NOT FREEZE. Please indicate Date of Bone Marrow Transplant.
Turnaround Time: Sample accepted daily by 11 am; Report available in 7 working days
